ProPhase Labs Inc. logo

ProPhase Labs Inc. (PRPH)

Market Closed
11 Jun, 20:00
OTC PINK OTC PINK
$
0. 09
-0.01
-10%
$
521.07K Market Cap
- P/E Ratio
- Div Yield
30,100 Volume
-1.55 Eps
$ 0.1
Previous Close
Investors:
Add Transaction
Day Range
0.09 0.1
Year Range
0.07 6.7
Want to track PRPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PRPH closed today lower at $0.09, a decrease of -10% from yesterday's close, completing a monthly decrease of -25% or -$0.03. Over the past 12 months, PRPH stock lost -80.6076%.
PRPH pays dividends to its shareholders, with the most recent payment made on Jun 03, 2022. The next estimated payment will be in 3 Jun 2022 on Jun 03, 2022 for a total of $0.3.
The last earnings report, released on Apr 01, 2026, exceeded the consensus estimates by 0.12%. On average, the company has surpassed earnings expectations by 0.1267%, based on the last three reports.
ProPhase Labs Inc. has completed 2 stock splits, with the recent split occurring on Dec 22, 2025.
The company's stock is traded on one exchange.

PRPH Chart

ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript

ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript

ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript

Seekingalpha | 6 months ago
ProPhase Labs, Inc. (PRPH) Q2 2025 Earnings Call Transcript

ProPhase Labs, Inc. (PRPH) Q2 2025 Earnings Call Transcript

ProPhase Labs, Inc. (NASDAQ:PRPH ) Q2 2025 Earnings Conference Call August 13, 2025 2:00 PM ET Company Participants Ted William Karkus - Chairman & CEO Operator Welcome to today's presentation. My name is Noella Alexander-Young, virtual event moderator here at Renmark Financial Communications.

Seekingalpha | 9 months ago
ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call Transcript

ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call Transcript

ProPhase Labs, Inc. (NASDAQ:PRPH ) Q1 2025 Earnings Conference Call May 20, 2025 10:00 AM ET Company Participants Noella Alexander-Young - Virtual Event Moderator, Renmark Financial Communications Ted Karkus - Chief Executive Officer Noella Alexander-Young Hello, and good morning everyone. Welcome to today's presentation.

Seekingalpha | 1 year ago

ProPhase Labs Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
CAL
CoreCap Advisors LLC CoreCap Advisors LLC
720 $324 $72 -$252 -77.78%
Christopher C. Powers
Christopher C. Powers Farther Finance Advisors, LLC
9 $4 $0.9 -$3.1 -77.5%

ProPhase Labs Inc. (PRPH) FAQ

What is the stock price today?

The current price is $0.09.

On which exchange is it traded?

ProPhase Labs Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is PRPH.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 521.07K.

Has ProPhase Labs Inc. ever had a stock split?

ProPhase Labs Inc. had 2 splits and the recent split was on Dec 22, 2025.

ProPhase Labs Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ted William Karkus CEO
OTC PINK Exchange
74345W108 CUSIP
US Country
96 Employees
3 Jun 2022 Last Dividend
22 Dec 2025 Last Split
16 Jan 1997 IPO Date

Overview

ProPhase Labs, Inc., initially known as The Quigley Corporation, is a company dedicated to the development and commercialization of novel drugs, dietary supplements, and various compounds within the United States. The company has diversified its operations into two main segments: Diagnostic Services and Consumer Products, offering a broad spectrum of services and products ranging from health supplements to diagnostic services. Founded in 1989, ProPhase Labs has established its headquarters in Garden City, New York, indicating a longstanding presence and experience in the healthcare and consumer products sectors.

Products and Services

  • Health Supplements:

    Among its range of products, ProPhase Labs offers TK supplements targeted at enhancing male sexual health under the brand Legendz XL, and Triple Edge XL, aimed at boosting energy and stamina. These products reflect the company's focus on addressing specific health and wellness needs through over-the-counter (OTC) consumer healthcare products.

  • Contract Manufacturing Services:

    The company extends its expertise by offering comprehensive contract manufacturing services, which encompass product development, pre-commercialization, production, warehousing, and distribution. This suite of services supports other businesses in bringing their health and wellness products to market efficiently.

  • Diagnosis Services:

    Providing COVID-19 diagnostic information services has positioned ProPhase Labs as a crucial entity during and beyond the pandemic, catering to a diversified clientele including health plans, third-party payers, and government organizations. The company also offers respiratory pathogen panel molecular testing services, underscoring its capability in diagnosing a range of viral and bacterial infections alongside its COVID-19 testing.

  • Personal Genomics Products and Services:

    Expanding into the personal genomics space, ProPhase Labs delivers products and services that allow individuals to explore their genetic information. This initiative signifies the company’s commitment to leveraging advanced technologies for enhancing personal health and wellness.

  • Retail Operations:

    The final aspect of ProPhase Labs’ operations involves the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements. This range underscores the company’s extensive involvement in the consumer healthcare sector, catering to various customer needs from prevention to treatment.

Contact Information

Address: 711 Stewart Avenue
Phone: 215 345 0919